Sanara Medtech Inc
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness w… Read more
Market Cap & Net Worth: Sanara Medtech Inc (SMTI)
Sanara Medtech Inc (NASDAQ:SMTI) has a market capitalization of $175.32 Million ($175.32 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #19656 globally and #7208 in its home market, demonstrating a -5.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sanara Medtech Inc's stock price $19.62 by its total outstanding shares 8935657 (8.94 Million).
Sanara Medtech Inc Market Cap History: 2015 to 2026
Sanara Medtech Inc's market capitalization history from 2015 to 2026. Data shows growth from $80.42 Million to $175.32 Million (10.40% CAGR).
Index Memberships
Sanara Medtech Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #542 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1798 of 3165 |
Weight: Sanara Medtech Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sanara Medtech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sanara Medtech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.42x
Sanara Medtech Inc's market cap is 3.42 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $80.42 Million | $3.37 Million | -$1.34 Million | 23.85x | N/A |
| 2016 | $35.74 Million | $5.51 Million | -$415.75K | 6.49x | N/A |
| 2017 | $53.61 Million | $6.30 Million | $331.31K | 8.50x | 161.82x |
| 2018 | $26.81 Million | $5.84 Million | -$600.57K | 4.59x | N/A |
| 2019 | $143.86 Million | $11.77 Million | -$2.81 Million | 12.23x | N/A |
| 2020 | $445.89 Million | $15.59 Million | -$4.36 Million | 28.61x | N/A |
| 2021 | $264.05 Million | $24.14 Million | -$7.92 Million | 10.94x | N/A |
| 2022 | $406.57 Million | $45.84 Million | -$7.94 Million | 8.87x | N/A |
| 2023 | $367.26 Million | $64.99 Million | -$4.30 Million | 5.65x | N/A |
| 2024 | $296.66 Million | $86.67 Million | -$9.66 Million | 3.42x | N/A |
Competitor Companies of SMTI by Market Capitalization
Companies near Sanara Medtech Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Sanara Medtech Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Sanara Medtech Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Sanara Medtech Inc's market cap moved from $80.42 Million to $ 175.32 Million, with a yearly change of 10.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $175.32 Million | -15.97% |
| 2025 | $208.65 Million | -29.67% |
| 2024 | $296.66 Million | -19.22% |
| 2023 | $367.26 Million | -9.67% |
| 2022 | $406.57 Million | +53.98% |
| 2021 | $264.05 Million | -40.78% |
| 2020 | $445.89 Million | +209.94% |
| 2019 | $143.86 Million | +436.67% |
| 2018 | $26.81 Million | -50.00% |
| 2017 | $53.61 Million | +50.00% |
| 2016 | $35.74 Million | -55.56% |
| 2015 | $80.42 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sanara Medtech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $175.32 Million USD |
| MoneyControl | $175.32 Million USD |
| MarketWatch | $175.32 Million USD |
| marketcap.company | $175.32 Million USD |
| Reuters | $175.32 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.